Synergistic effect of a novel autophagy inhibitor and Quizartinib enhances cancer cell death

Drug combinations have been increasingly applied in chemotherapy as a strategy to enhance the efficacy of anti-cancer treatment. The appropriate drug combinations may achieve synergistic effects beyond monotherapies alone. AC220 (Quizartinib), an FLT3 receptor tyrosine kinase inhibitor, developed fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouchida, Amanda Tomie, Li, Yingbo, Geng, Jiefei, Najafov, Ayaz, Ofengeim, Dimitry, Sun, Xiaoxiao, Yu, Qiang, Yuan, Junying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833862/
https://www.ncbi.nlm.nih.gov/pubmed/29374185
http://dx.doi.org/10.1038/s41419-017-0170-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833862/
https://www.ncbi.nlm.nih.gov/pubmed/29374185
http://dx.doi.org/10.1038/s41419-017-0170-9

Ejemplares similares